Nørgaard-Pedersen C

ORCID: 0000-0001-9609-8396 · 1 paper in corpus

2025

Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a randomised, double-blind, placebo-controlled trial.

BMJ open ·doi:10.1136/bmjopen-2025-106024

ObjectiveTo investigate whether treatment with oral corticosteroids and intravenous immunoglobulin (IVIg) improves pregnancy outcomes in women with unexplained recurrent pregnancy loss (RPL) following assisted reproduction technology (ART) …